Evidence map›Paper›PMID 42274358›Full record

ArticleThe Journal of clinical endocrinology and metabolism2026

Cancer risk in acromegaly: reassessing the evidence and impact of biochemical control.

Maria Fleseriu, Shlomo Melmed

Abstract readComment
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Maria FleseriuDepartments of Medicine and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-9284-6289
Shlomo MelmedDepartment of Medicine and Pituitary Center, Cedars-Sinai Health Sciences University, Los Angeles, CA 90048, USA.ORCID 0000-0002-2355-3447

Funding

Mechanisms for GH action on epithelial cellsR01DK113998 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI SHLOMO MELMED · 2018 to 2026
$3.0M
NIDDK NIH HHS R01 DK113998NIDDK NIH HHS R01DK113998
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acromegalybiochemical controlcancerGH/IGF-1 axismortalityscreening

Identifiers

PMID42274358
PMCPMC13577762

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.